Skip to main content

CORRECTION article

Front. Pharmacol., 27 April 2021
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 12 - 2021 | https://doi.org/10.3389/fphar.2021.652927
This article is part of the Research Topic Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man View all 11 articles

Corrigendum: Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders Research Topic: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man

This article is a correction to:

  1. Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders

    1. Read original article
Chlo Melchior,, Chloé Melchior1,2,3*Charlotte Desprez,,Charlotte Desprez1,3,4Fabien Wuestenberghs,,Fabien Wuestenberghs1,4,5Anne-Marie Leroi,,Anne-Marie Leroi1,3,4Antoine LemaireAntoine Lemaire6Guillaume Gourcerol,,Guillaume Gourcerol1,3,4
  • 1INSERM UMR 1073, Institute for Research and Innovation in Biomedicine, Normandy University, Rouen, France
  • 2Gastroenterology Department, Rouen University Hospital, Rouen, France
  • 3INSERM CIC-CRB 1404, Rouen University Hospital, Rouen, France
  • 4Physiology Department Rouen University Hospital, Rouen, France
  • 5Gastroenterology Department, CHU UCL Namur, Godinne University Hospital, UCLouvain, Yvoir, Belgium
  • 6Pain and Palliative Care Department, Valenciennes Hospital, Valenciennes, France

A corrigendum on
Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders Research Topic: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man

by Melchior, C., Desprez, C., Wuestenberghs, F., Leroi, A.-M., Lemaire, A., and Gourcerol G. (2020). Front. Pharmacol. 11, 596467. 10.3389/fphar.2020.596467

An author name was incorrectly spelled as Goucerol. The correct spelling is Gourcerol. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: opioid, functional gastrointestinal disorder, tramadol, constipation, vomiting, quality of life

Citation: Melchior C, Desprez C, Wuestenberghs F, Leroi A-M, Lemaire A and Gourcerol G (2021) Corrigendum: Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders Research Topic: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man. Front. Pharmacol. 12:652927. doi: 10.3389/fphar.2021.652927

Received: 13 January 2021; Accepted: 29 March 2021;
Published: 27 April 2021.

Edited and reviewed by:

Angelo A. Izzo, University of Naples Federico II, Italy

Copyright © 2021 Melchior, Desprez, Wuestenberghs, Leroi, Lemaire and Gourcerol. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Chloé Melchior, chloe.melchior@chu-rouen.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.